L-Phe-Phe-Phe, Agonist of TAS2R1, CAS No.rp174469, Agonist of TAS2R1

CAS: rp174469 Cat. No.: rp174469
주문 가능
등급 & 순도 Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
★
크기
USA
독일 (EU)*
가격
수량
500μg
rp174469-500μg
US 주문제작 · 2–4주 ·
—
US$2,399.90
1mg
rp174469-1mg
US 주문제작 · 2–4주 ·
—
US$3,999.90
Enter a quantity for the sizes you want to add.

사양

Product Name
L-Phe-Phe-Phe, Agonist of TAS2R1, CAS No.rp174469
등급
Moligand™
사양 및 순도
Moligand™
작업 유형
AGONIST
작동 메커니즘
Agonist of TAS2R1
CAS
rp174469
분자 유형
Peptide
Product Line
생물 제품
보관 및 배송
보관 조건
Room temperature

고급 데이터

관련 대상(인간)
TAS2R1 Tchem Taste receptor type 2 member 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
인증서(CoA, COO, BSE/TSE 및 분석 차트)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
유전 정보
Reference
  • 1. Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration., The Journal of biological chemistry, Steegborn, C C and 7 more authors.
  • 2. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proceedings of the National Academy of Sciences of the United States of America, Strausberg, Robert L RL and 83 more authors.
  • 3. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)., Human genetics, Wang, Jian J and Hegele, Robert A RA.
  • 4. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase., Biochemical and biophysical research communications, Lu, Y Y, O'Dowd, B F BF, Orrego, H H and Israel, Y Y.
  • 5. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration., Clinical genetics, Wang, J J, Huff, A M AM, Spence, J D JD and Hegele, R A RA.
  • 6. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1., The Journal of biological chemistry, Yang, Guangdong G, Cao, Kun K, Wu, Lingyun L and Wang, Rui R.
  • 7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)., Genome research, Gerhard, Daniela S DS and 115 more authors.
  • 8. Towards a proteome-scale map of the human protein-protein interaction network., Nature, Rual, Jean-François JF and 37 more authors.
  • 9. The DNA sequence and biological annotation of human chromosome 1., Nature, Gregory, S G SG and 178 more authors.
  • 10. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer., International journal of cancer, Moore, Lee E LE and 14 more authors. more
솔루션 계산기
리뷰

고객 리뷰

Application Protocols

Tested application details are not provided for this item.

General preparation guidance (research use; optimize for your assay):

  • Stock solution
    • Weigh in a fume hood to minimize dust. Prepare a 10–50 mM stock in DMSO or DMF. Vortex and sonicate if needed. Filter (0.22 µm PTFE) to clarify if required.
  • Aqueous working solutions
    • Add the organic stock slowly into vigorously stirred buffer (e.g., PBS, HEPES) to a final organic content ≤5–10% v/v. Adjust pH modestly to improve clarity (avoid extremes that promote hydrolysis).
  • Self‑assembly studies
    • Use a consistent solvent‑switch protocol (e.g., 10× DMSO stock into water to reach target concentration). Allow equilibration (30–120 min) before measurements. Document temperature, ionic strength, and pH.
  • Conjugation (EDC/NHS example)
    • Activate C‑terminus in MES pH 5.5 (EDC/NHS, 10–30 min), then couple to amine‑bearing partner at pH 7.5–8.5. Purify by RP‑HPLC.

Note: The above are illustrative, literature‑based workflows. Specific validated applications or dilutions for this catalog item are Not specified for this item; refer to CoA/Spec Sheet.

Biological Roles
  • General biochemical context (literature)

    • Phenylalanine (Phe) is a hydrophobic, aromatic amino acid; oligomers enriched in Phe engage in π–π stacking and hydrophobic interactions that can modulate protein–protein interactions and phase behavior in vitro.
    • Short Phe‑rich motifs (e.g., Phe–Phe) are recognized by chymotrypsin‑like proteases and are often used in model substrates to probe specificity, kinetics, and inhibitor design (when labeled appropriately).
  • Interactions and assembly

    • L‑Phe‑Phe‑Phe can self‑associate through side‑chain aromatic stacking and backbone hydrogen bonding, forming higher‑order assemblies under suitable conditions. Such assemblies are studied as minimalistic models for peptide aggregation and as scaffolds in biomaterials research.
  • Transport and metabolism (general)

    • Unmodified tripeptides can be taken up by peptide transporters (e.g., PepT family) in some biological systems; however, actual uptake and processing depend on sequence, charge state, and experimental context. No item‑specific biological data are provided here.
  • Important note

    • No medical, diagnostic, or therapeutic claims are made. Use is restricted to research applications such as enzyme assays, binding/aggregation studies, and materials science experiments.
Buffer Applications

This product is a hydrophobic tripeptide and is not a buffering reagent.

  • Not typically used to control pH or as a classical buffer component. Instead, choose Good’s buffers (e.g., HEPES, MOPS), phosphate, Tris, or acetate for pH control in peptide assays.
  • Practical relevance
    • In peptide analytics, mobile phases may include water/acetonitrile with 0.1% formic acid or TFA; the peptide is the analyte, not the buffer.
    • For dissolution, prepare a DMSO stock and dilute into the buffer of choice (confirm assay tolerance to organic co‑solvent). Adjusting pH can aid solubility but does not confer buffering capacity.
Green Alternatives

Greener handling for hydrophobic peptides focuses on solvent and process choices rather than replacing the compound itself.

  • Preferred greener solvents (when compatible)

    • Water or buffered saline with minimal co‑solvent (≤5–10% v/v) after preparing a concentrated DMSO seed stock.
    • Bio‑derived solvents such as 2‑MeTHF or Cyrene are generally not effective for dissolution but can be used for some workups; their utility is limited for peptides.
    • Ethanol (Ph. Eur./USP grade) can sometimes assist as a co‑solvent in biophysical assays at low percentages.
  • Process intensification

    • Use sonication, gentle warming (≤40–50 °C), and pH adjustment to reduce the required organic solvent load.
    • Employ microscale high‑throughput screening to minimize material consumption.

Comparison (general)

  • DMSO vs water‑rich systems

    • DMSO: excellent solubilizer but persistent in waste streams; manage via segregation and solvent recovery where possible.
    • Water with co‑solvent: greener footprint; may require more optimization (pH, ionic strength) to avoid precipitation/aggregation.
  • Waste and safety

    • Consolidate DMSO/DMF wastes; avoid halogenated solvents.
    • Prefer LC‑MS mobile phases using formic acid over TFA when high ionization efficiency is needed, reducing re‑runs and solvent consumption.
Pharmaceutical Uses

No pharmaceutical or clinical claims are made for this product. It is supplied strictly for research use.

  • Typical roles in pharmaceutical research (general)

    • Tool compound in early discovery to probe peptide‑recognition sites or to study hydrophobic/aromatic interactions.
    • Model substrate or sequence motif for protease assay development after conjugation with chromogenic/fluorogenic reporters.
    • Materials R&D: component of peptide‑based hydrogels or nanostructures used to study delivery concepts in vitro.
  • Excipient/formulation status

    • Not known or intended as a pharmaceutical excipient. Any formulation studies should be confined to research settings.
  • Compliance

    • Not specified for this item; refer to CoA/Spec Sheet for any available compendial or analytical information relevant to method development.
Physical Properties

Peptide‑type materials such as L‑Phe‑Phe‑Phe exhibit properties governed by hydrogen bonding and hydrophobic side chains.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point / decomposition: Not specified for this item; refer to CoA/Spec Sheet. (Peptides often show broad decomposition rather than a sharp melt; literature, general.)
  • Solubility (general, literature guidance)
    • Water: typically low at neutral pH due to three hydrophobic phenyl side chains; solubility can increase upon pH adjustment (e.g., basic pH to form the carboxylate, or acidic pH to protonate the N‑terminus) and with vigorous stirring/sonication.
    • Organic solvents: DMSO and DMF are commonly effective; aqueous acetonitrile with 0.1% TFA or 0.1% formic acid can aid analytical work. Alcohols (MeOH/EtOH) may partially dissolve at elevated temperature with sonication.
    • Surfactant‑assisted: small amounts of Tween‑20 or bile salt surfactants can enhance aqueous dispersion for biophysical assays (general practice).
  • pKa / logP: Not specified for this item; refer to CoA/Spec Sheet. (Peptide apparent pKa values are context‑dependent; literature, general.)
  • Density, refractive index, UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Practical note (general): For hydrophobic short peptides, warming to 37–50 °C, brief vortex/sonication, and stepwise addition of water into a concentrated DMSO stock (≤10% DMSO final) often produces clear solutions for assays.

Quality and Grades
  • Grade/Purity: Moligand™ (as provided in Product Data)

    • Moligand™ items are intended for research screening and discovery workflows where consistent identity and cleanliness support biophysical/chemical assays. Specific purity metrics (e.g., HPLC area %, residual solvents, water content, counterions) are not stated here.
    • Item‑specific acceptance criteria (purity, residuals, peptide content, counterion) are Not specified for this item; refer to CoA/Spec Sheet.
  • What grade implies (general guidance for peptide/screening grade)

    • Emphasis on correct structure/sequence and suitability for compound library use (e.g., HTS, ligand screening, biophysical binding assays).
    • Typical analytical controls for such grade may include LC‑MS identity confirmation and chromatographic purity assessment; exact methods/limits vary by lot and are provided on the CoA when applicable.
  • Stabilizers/additives

    • No stabilizer information provided in Product Data. If present, the CoA will state any counter‑ions (e.g., TFA salt) or residual protecting groups; verify compatibility with planned assays.
  • When to choose Moligand™ grade

    • Appropriate for target engagement screens, materials self‑assembly studies, and method development.
    • For regulated applications or quantitative reference standards, request tighter specifications or additional documentation as needed.
Reaction and Applications

Applications for L‑Phe‑Phe‑Phe span peptide chemistry, supramolecular materials, and assay development.

  • Supramolecular/self‑assembly (literature/general)
    • Triple phenyl side chains promote π–π stacking and hydrophobic collapse, enabling formation of nanofibers, hydrogels, and organogels under suitable conditions (e.g., pH triggers, solvent switch, or salt addition). Useful in studying aromatic interactions and peptide‑based materials.
  • Biophysical/ligand screening
    • As an aromatic, neutral tripeptide, it can serve as a probe or ligand candidate in Moligand™ screening collections to interrogate peptide‑recognition sites, aromatic boxes, or chaperone‑like binding surfaces.
  • Protease substrate/model
    • The Phe–Phe scissile motif is characteristic for chymotrypsin‑like specificity; L‑Phe‑Phe‑Phe can be a model peptide in enzymology studies after appropriate labeling or conjugation (general concept; design dependent).
  • Building block in synthesis
    • N‑terminal amine and C‑terminal carboxylate allow elongation to tetra‑/oligopeptides or conjugation to dyes, lipids, and polymers (e.g., via EDC/NHS coupling) to create amphiphiles or imaging probes.

Practical tips

  • Ensure complete dissolution (DMSO/DMF, then aqueous dilution) before self‑assembly experiments; concentration and solvent history critically affect morphology.
  • For conjugations, confirm terminal functionality (free vs protected) on the CoA; deprotect if necessary under peptide‑compatible conditions.
Reaction Conditions

General conditions relevant to using L‑Phe‑Phe‑Phe in synthesis or assembly (literature guidance; not item‑specific specifications):

  • Amide bond formation (fragment coupling)

    • Solvents: DMF, NMP, or DCM/DMF mixtures.
    • Coupling reagents: HATU, HBTU, PyBOP, or EDC·HCl with Oxyma/HOAt; DIPEA or NMM as base.
    • Temperature: 0–25 °C (to limit racemization); times: 0.5–4 h typical.
    • Notes: Monitor by LC‑MS; protect free N‑terminus/C‑terminus as required to control chemoselectivity.
  • Carboxyl activation for surface/amide conjugation

    • EDC/NHS in MES buffer pH 5.0–6.0; couple to amines at pH 7.2–8.5. Quench residual active esters to avoid nonspecific binding.
  • Self‑assembly/hydrogel formation

    • Initiation via solvent switch (DMSO stock into water/buffer), pH change, or salt addition.
    • Concentration: often mM–10s of mM range; optimize empirically.
    • Characterization: CD, FTIR (amide I/II), TEM/AFM, rheology.
  • Analytical methods

    • RP‑HPLC with water/MeCN gradients containing 0.1% TFA (UV 214 nm) or 0.1% formic acid for LC‑MS.
    • MS: ESI positive mode commonly shows [M+H]+; verify exact mass on CoA.

All conditions above are general literature practices for hydrophobic tripeptides and should be optimized for the specific lot/formulation.

Safety and Handling
  • GHS classification, signal word, pictograms, H‑statements: Not specified for this item; refer to SDS.
  • General hazard profile (peptide solids; literature/general)
    • Typically low volatility and low acute toxicity; treat as a chemical of unknown hazards.
    • Dust may cause mechanical irritation to eyes/respiratory tract. Avoid inhalation and contact.
  • Personal protective equipment (PPE)
    • Lab coat, safety glasses, and nitrile gloves as standard.
    • Use a chemical fume hood for weighing/dissolution to minimize dust and aerosol exposure.
  • Handling
    • Avoid creating dust; use antistatic spatulas and weigh boats.
    • Dissolve initially in a suitable organic co‑solvent (e.g., DMSO/DMF) before aqueous dilution to limit aerosol formation and ensure complete dissolution.
  • Incompatibilities (general)
    • Strong oxidizers may degrade aromatic residues; strong acids/bases can cause hydrolysis with prolonged exposure or elevated temperature.
    • Moisture can promote aggregation or hydrolysis over time; keep containers tightly closed with desiccant.
  • First aid (overview; defer to SDS)
    • Skin/eye contact: rinse with water for ≥15 min; remove contaminated clothing; seek medical attention if irritation persists.
    • Inhalation: move to fresh air; seek attention if symptoms occur.
    • Ingestion: rinse mouth; do not induce vomiting; seek medical advice.
  • Waste disposal
    • Collect aqueous/organic solutions as laboratory chemical waste per institutional and local regulations; do not discharge to drains.
Solvent Selection

L‑Phe‑Phe‑Phe is a hydrophobic, aromatic tripeptide that benefits from polar aprotic solvents and co‑solvent strategies.

  • Primary solvents (general recommendations)
    • DMSO: excellent first choice for stock solutions (10–100 mM typical); miscible with water for subsequent dilution.
    • DMF or NMP: effective for concentrated stocks; suitable for peptide coupling workflows.
    • Aqueous acetonitrile (10–50%) with 0.1% TFA or formic acid: useful for LC/HPLC preparations and analytical injections.
  • Aqueous dissolution strategy
    • Adjust pH slightly basic (e.g., pH 8–9) to ionize the C‑terminus, or slightly acidic to protonate the N‑terminus; combine with gentle warming and sonication.
    • Maintain final organic co‑solvent ≤10% v/v for most biochemical assays; confirm assay tolerance.
  • Solvents to avoid/limit
    • Nonpolar hydrocarbons (hexanes, toluene) show negligible solubility.
    • Strong acids/bases at elevated temperature can cause hydrolysis over time.

Comparison (general)

  • DMSO vs DMF: DMSO is broadly biocompatible at low % and less noxious odor; DMF may offer slightly faster dissolution for some peptides but is less favored in biological assays.
  • Aqueous MeCN + 0.1% TFA: excellent for HPLC but TFA may suppress MS signals; for LC‑MS use 0.1% formic acid instead.
Storage and Reconstitution
  • Storage conditions (from Product Data)

    • Store at room temperature. Keep tightly capped, dry, and protected from light and reactive vapors. For long‑term retention of quality, many peptide users prefer desiccated storage in the dark.
  • Shipping: Not specified for this item; refer to CoA/Spec Sheet.

  • Reconstitution

    • Solvent choice: DMSO or DMF for initial stock; for aqueous uses, dilute into buffer to a final organic content compatible with your assay.
    • Concentration: choose based on assay (common peptide stock range 10–50 mM); confirm solubility visually. If needed, warm gently (≤40–50 °C) and sonicate.
    • Filtration: If particulate persists, sterile‑filter through 0.22 µm PTFE (organic) or PVDF (aqueous) filters as appropriate.
  • Aliquoting and stability (general guidance)

    • Prepare single‑use aliquots to avoid repeated opening. Minimize headspace and moisture ingress (use desiccant and inert gas purge if available).
    • Aqueous solutions are best used fresh; if storage is necessary, keep at 2–8 °C for short term. For longer storage, freeze at −20 °C or below in aliquots; avoid repeated freeze–thaw.
  • Item‑specific stability data (e.g., shelf life, degradation pathways): Not specified for this item; refer to CoA/Spec Sheet.

  • Research Use Only: as stated in Product Data.

Structure and Identity

L‑Phe‑Phe‑Phe is the L‑configured tripeptide composed of three L‑phenylalanine residues (sequence: L‑Phe–L‑Phe–L‑Phe). It presents a linear peptide backbone with two internal amide bonds and three para‑substituted phenyl (benzyl) side chains.

  • Item identity

    • SKU: rp174469
    • Product name: L‑Phe‑Phe‑Phe (L‑phenylalanyl‑L‑phenylalanyl‑L‑phenylalanine)
    • Category: Small molecules and compound library (小分子和化合物库)
    • Grade: Moligand™
  • Structural features (general description)

    • Linear tripeptide: H–Phe–Phe–Phe–OH (free N‑terminus and free C‑terminus; protecting groups not indicated in Product Data)
    • Functional groups: primary amine (α‑NH2, if not protonated), two secondary amide linkages (peptide bonds), terminal carboxylic acid (α‑CO2H), three benzyl/phenyl side chains enabling π–π stacking and hydrophobic interactions
    • Stereochemistry: all α‑centers are L (S) configuration as typical for L‑phenylalanine residues
  • 2D structure in words

    • Backbone: –NH–CH(CH2Ph)–CO–NH–CH(CH2Ph)–CO–NH–CH(CH2Ph)–CO2H
    • Side chains: each α‑carbon bears a –CH2–C6H5 substituent (phenyl)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.

  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Synthetic Utility

As a linear tripeptide bearing free termini, L‑Phe‑Phe‑Phe offers multiple points for derivatization and conjugation.

  • Functional handles

    • N‑terminus (α‑amine): acylation, carbamylation, urea formation, labeling with NHS‑activated dyes or PEGs.
    • C‑terminus (α‑carboxylate): EDC/NHS coupling to amines, amidation to generate C‑terminal amides, or immobilization on amine‑functionalized surfaces.
    • Side chains (phenyl): electrophilic aromatic substitution is generally not selective; prefer linker strategies via termini. Benzylic oxidation or radical additions are rarely used for delicate peptides.
  • Use in sequence extension

    • SPPS or solution‑phase peptide synthesis can extend from either terminus to build tailored oligomers (e.g., adding charged residues to tune solubility or self‑assembly).
  • Conjugates and architectures

    • Formation of amphiphilic peptide–lipid conjugates, peptide–polymer hybrids, or FRET/fluorophore‑tagged probes for biophysical assays.
  • Retrosynthetic perspective

    • The tripeptide can replace a multi‑step assembly when used as a pre‑formed fragment in fragment condensation strategies, reducing coupling cycles and racemization risks (general practice). Verify terminal protection status on the CoA before planning couplings.
Target Specificity

This product is a small‑molecule/peptide reagent, not an antibody or biologic. No antigen/epitope, clone, isotype, or species reactivity is applicable.

  • Target specificity data: Not specified for this item; refer to CoA/Spec Sheet if any binding data are provided for particular targets in screening contexts.

자주 묻는 질문

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is rp174469.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

등급 선택에 도움이 필요하신가요?

당사의 등급 선택 가이드는 카탈로그의 모든 변형 제품에 대해 순도, 안정제 상태 및 용도 적합성을 다룹니다.

Moligand™ 등급 가이드 보기 →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.